CNO Financial (NYSE: CNO) executive granted shares and new RSUs

Rhea-AI Filing Summary

CNO Financial Group officer Karen J. DeToro, President of the Worksite Division, reported equity compensation changes. On February 10, 2026, she acquired 13,835 shares of common stock at $43.05 per share upon vesting of performance share units tied to 2023–2025 operating and shareholder return metrics.

On the same date, 6,135 shares were surrendered back to CNO Financial at $43.05 per share to cover required tax withholding on the vested performance share units. She also received a grant of 7,900 restricted stock units at $0, which convert one-for-one into common stock and vest in three equal annual installments beginning on March 25, 2027, subject to continued employment.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider DeToro Karen J.

Role President, Worksite Division

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,835	$43.05	$596K
Tax Withholding	Common Stock	6,135	$43.05	$264K
Grant/Award	Restricted Stock Units	7,900	$0.00	--

Holdings After Transaction: Common Stock — 52,815 shares (Direct); Restricted Stock Units — 54,580 shares (Direct)

Footnotes (1)

1. Shares were acquired upon the vesting of performance share units for the 2023-2025 performance period, based on the issuer's (i) 2023 operating return on equity, (ii) 2023 operating earnings per share and (iii) three-year relative total shareholder return for 2023-2025. Shares were surrendered to the issuer to cover the required tax withholding on the vested performance share units. Restricted stock units convert into common stock on a one-for-one basis. The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeToro Karen J.

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Worksite Division

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		A		13,835(1)	A	$43.05	52,815	D
Common Stock	02/10/2026		F		6,135(2)	D	$43.05	46,680	D
Restricted Stock Units(3)(4)	02/10/2026		A		7,900	A	$0	54,580	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were acquired upon the vesting of performance share units for the 2023-2025 performance period, based on the issuer's (i) 2023 operating return on equity, (ii) 2023 operating earnings per share and (iii) three-year relative total shareholder return for 2023-2025.

2. Shares were surrendered to the issuer to cover the required tax withholding on the vested performance share units.

3. Restricted stock units convert into common stock on a one-for-one basis.

4. The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did CNO (CNO) executive Karen J. DeToro report?

Karen J. DeToro reported vesting-related equity changes. She acquired 13,835 CNO common shares from performance share units and surrendered 6,135 shares to cover tax withholding. She also received 7,900 restricted stock units that vest over three years starting March 25, 2027.

How many CNO (CNO) shares did Karen J. DeToro acquire and surrender?

DeToro acquired 13,835 CNO common shares at $43.05 per share from vested performance share units. She then surrendered 6,135 shares, also at $43.05 per share, back to the company to satisfy required tax withholding on those newly vested shares.

What restricted stock units did CNO (CNO) grant to Karen J. DeToro?

DeToro received 7,900 restricted stock units at a price of $0. Each unit converts into one CNO common share. The units vest in three equal annual installments beginning March 25, 2027, contingent on her continued employment with CNO or its subsidiaries.

What performance metrics drove Karen J. DeToro’s vested CNO (CNO) share units?

The vested performance share units were based on CNO’s 2023 operating return on equity, 2023 operating earnings per share, and three-year relative total shareholder return for 2023–2025. These company performance measures determined the number of shares ultimately delivered to DeToro.

Why did Karen J. DeToro surrender CNO (CNO) shares in this Form 4?

DeToro surrendered 6,135 CNO common shares to the issuer to cover required tax withholding on vested performance share units. This is a non-open-market disposition where shares are returned to the company instead of paying the withholding obligation in cash.

How do Karen J. DeToro’s CNO (CNO) restricted stock units convert into shares?

Her restricted stock units convert into CNO common stock on a one-for-one basis. As each of the three annual vesting installments occurs starting March 25, 2027, one CNO share will be issued for each vested restricted stock unit, assuming continued qualifying employment.